Page 29 - Use Authorization News Today

LH earnings call for the period ending December 31, 2021.

Bebtelovimab (LY-CoV1404) neutralizes Omicron, including the subvariant BA.2, as demonstrated by pseudovirus and/or authentic virus dataPreviously reported data show that bebtelovimab has broad and potent neutralization of all other known circulating SARS-CoV-2 variants of concernBebtelovimab binds to a rarely mutat...

LH earnings call for the period ending December 31, 2021.

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation...

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Pfizer (NYSE:PFE) is scheduled to announce Q4 earnings results on Tuesday, February 8th, before market open.The consensus EPS Estimate is $0.87 (+107.1% Y/Y) and the consensus...

Theres a push for Pfizer to apply for a FDA Emergency Use Authorization for a two dose vaccine. The shot would be for children ages six months to five years

Moderna won its first FDA approval.

DENTON, Texas, Feb. 1, 2022 /PRNewswire/ -- HealthTrackRx, the nations leading polymerase chain reaction (PCR) testing lab, today announced Barba...